Which Products Has Kala Pharmaceuticals Developed Using This Technology?
Kala Pharmaceuticals has developed several products using its MPP technology, with a focus on treating ocular diseases. One of their most notable products is EYSUVIS (loteprednol etabonate suspension 0.25%), which is formulated to treat dry eye disease. Another product, INVELTYS, is a corticosteroid for pain and inflammation post-ocular surgery. Both products leverage the MPP technology to enhance drug penetration and retention in the eye, offering improved therapeutic outcomes.
